Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

"Site License" Reimbursement Model For Limited Use Antibacterials Being Explored By US FDA, CMS

31 Jul 2018

• By Michael Cipriano

Antibiotic resistant bacteria closeup biofilm

Related Content

New Report Calls For Pushing And Pulling In Global Fight Against Superbugs

24 Jan 2018

Related Companies

F2G Ltd

AstraZeneca PLC

Additional Topics

United States Reimbursement Regulation Infectious Diseases BioPharmaceutical

More from Market Access

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.